Our discovery of this potential novel interaction between platelet-derived TSP1, Nrg4, brown fat, and the liver may add a new layer of complexity to our understanding of NASH progression. The gene discussed is NRG4; the disease is metabolic dysfunction-associated steatohepatitis.